J9281 HCPCS Level II code: Mitomycin pyelocalyceal instillation, 1 mg
J9281 is the HCPCS code for “Mitomycin pyelocalyceal instillation, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9281Mitomycin pyelocalyceal instillation, 1 mg
Short description: Mitomycin instillation
HCPCS · United States
Medicare details
The indicators CMS publishes with J9281 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2021
Where J9281 sits
- 1J codesDrugs administered other than orally
- 2Active code J9281Mitomycin pyelocalyceal instillation, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9281 mean?
J9281 is the HCPCS code for “Mitomycin pyelocalyceal instillation, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9281?
CMS lists J9281’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9281
All J codesJ9274Injection, tebentafusp-tebn, 1 microgramJ9275Injection, cosibelimab-ipdl, 2 mgJ9276Injection, zanidatamab-hrii, 2 mgJ9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmphJ9278Injection, carboplatin (avyxa), 1 mgJ9280Injection, mitomycin, 5 mgJ9282Mitomycin, intravesical instillation, 1 mgJ9285Injection, olaratumab, 10 mgJ9286Injection, glofitamab-gxbm, 2.5 mgJ9289Injection, nivolumab, 2 mg and hyaluronidase-nvhyJ9292Injection, pemetrexed dipotassium, 10 mgJ9293Injection, mitoxantrone hydrochloride, per 5 mg